Skip to main content
Caplight Logo









Lamark Biotech

Lamark Biotech

Private
AhmedabadHealthcare & Life Scienceshttps://lamarkbiotech.com/

Last Round

Seed

Jul 1, 2025

Total Funding Raised

$804,300

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Lamark Biotech is a biotechnology company that develops thermostable biologics using its proprietary ProteoStrong platform to reduce cold-chain dependency for life-saving therapeutics.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

thermostable biologicscold-chain eliminationprotein stabilizationroom temperature drugsdrug formulationno-refrigeration medicineshelf-stable biologicsbiotech R&Dpharma supply chainmonoclonal antibodiesCDMOcontract developmentdrug accessibilitylast-mile pharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lamark Biotech Comparables

Compare Lamark Biotech with similar companies based on industry and business-model similarity.

Lamark Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
EnsiliTech
86%
Jurata Thin Film
84%
Inaedis Inc.
79%

Lamark Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2025
SeedMar 22, 2021

Key People

Founding team and executive leadership

Vaibhav Bhatia

Chief Executive Officer, Founder

Founding Team

Lamark Biotech Investors

Notable investors and investment history

Lamark Biotech investors
InvestorRounds
IAN GroupSeed
VIT-Technology Business IncubatorSeed
BioAngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 181% MoM, reaching 3K.

  • Jan 20, 2026

    Monthly visitors increased 1799% MoM, reaching 5.3K.

Lamark Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lamark Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lamark Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersAhmedabad
Employee Range13
Year Founded2018
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?